Equate Pain Relief Patch Camphor/Menthol/Salicylate

Description

No description information is available for the specified drug.

Uses and Indications

This drug is indicated for the temporary relief of minor aches and pains of muscles and joints associated with conditions such as arthritis, simple backache, muscle strains, muscle sprains, and bruises.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

For adults and children aged 12 years and over, the affected area should be cleaned and dried prior to application. The patch must be removed from its protective film and applied directly to the affected area. It is recommended that the patch be applied no more than 3 to 4 times daily. Each patch should not be used for more than 8 hours. After a single use, the patch should be discarded, and the pouch should be resealed immediately after opening to maintain product integrity.

For children under 12 years of age, it is advised to consult a healthcare professional before use.

Contraindications

The product is contraindicated in the following situations:

• Application on wounds or damaged skin due to the risk of irritation and adverse effects.

• Use in conjunction with a heating pad, as this may enhance absorption and increase the risk of systemic effects.

• In individuals with known allergies to any ingredients of this product, to prevent allergic reactions.

• Use contrary to the provided directions, as this may lead to unintended consequences.

Additionally, while using this product, it is important to avoid contact with the eyes, mucous membranes, or rashes to prevent irritation. Bandaging should not be done tightly to allow for proper circulation. Concurrent use with other topical analgesics is contraindicated to avoid potential additive effects.

Used patches should be disposed of properly, away from children and pets, as they still contain active drug that can cause serious adverse effects if ingested.

Warnings and Precautions

For external use only. Healthcare professionals should advise patients to consult a doctor prior to use if they have a known allergy to aspirin or salicylates.

This product should not be applied to wounds or damaged skin, nor should it be used in conjunction with a heating pad. Patients with known allergies to any ingredients in this product should refrain from use. It is imperative that the product is used strictly as directed to ensure safety and efficacy.

When utilizing this product, it is essential to adhere to the following precautions: apply only as directed, avoid contact with the eyes, mucous membranes, or rashes, and do not apply a tight bandage over the area of application. Concurrent use with other topical analgesics is contraindicated. Used patches must be disposed of properly, away from children and pets, as they still contain active drug components that could lead to serious adverse effects if ingested.

Patients should be instructed to discontinue use and seek medical advice if any of the following occur: rash, itching, or excessive skin irritation develops; if the condition worsens; or if symptoms persist for more than 7 days or resolve and then recur within a few days.

It is crucial to keep this product out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or contact with a Poison Control Center (1-800-222-1222) is recommended.

Side Effects

Patients using this product should be aware that it is intended for external use only. Individuals with a known allergy to aspirin or salicylates are advised to consult a healthcare professional prior to use. The product should not be applied to wounds or damaged skin, nor should it be used in conjunction with a heating pad. Additionally, it is contraindicated for those who are allergic to any of the product's ingredients and should not be used in any manner other than as directed.

While using this product, patients must adhere strictly to the instructions provided. Care should be taken to avoid contact with the eyes, mucous membranes, or rashes. It is important not to bandage the area tightly and to refrain from using other topical analgesics simultaneously. Used patches should be disposed of properly, as they still contain the drug product, which can pose serious risks if ingested by children or pets.

Patients are advised to discontinue use and seek medical attention if they experience rash, itching, or excessive skin irritation. They should also consult a doctor if their condition worsens or if symptoms persist for more than seven days, or if symptoms resolve and then recur within a few days.

In the event of accidental ingestion, immediate medical assistance should be sought, or the Poison Control Center (1-800-222-1222) should be contacted without delay.

Drug Interactions

There are currently no documented drug interactions associated with the use of this medication. Additionally, there is no information available regarding interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are warranted at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Equate Pain Relief Patch Camphor/Menthol/Salicylate (camphor, menthol, methyl salicylate). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients under 12 years of age should consult a healthcare professional prior to use. For adolescents aged 12 years and older, the recommended application is to the affected area no more than 3 to 4 times daily, with a maximum duration of use not exceeding 8 hours.

It is crucial to dispose of used patches safely, as they still contain the drug product, which can lead to serious adverse effects if ingested by children or pets. Therefore, used patches should be kept out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or contact with a Poison Control Center (1-800-222-1222) is advised.

Geriatric Use

Elderly patients may not have specific information regarding the use of this medication, including dosage adjustments, safety concerns, or special precautions. Therefore, healthcare providers should exercise caution when prescribing this medication to geriatric patients. It is advisable to monitor these patients closely for any adverse effects or changes in therapeutic response, given the lack of targeted data for this population.

Pregnancy

Pregnant patients and those who are breastfeeding should consult a healthcare professional prior to using this medication. It is important to assess the potential risks and benefits associated with the use of this drug during pregnancy and lactation. Healthcare providers can offer guidance based on individual circumstances and the latest clinical data.

Lactation

Lactating mothers are advised to consult a health professional prior to using this medication. There is currently no available data regarding the excretion of this medication in human breast milk or its effects on breastfed infants. Therefore, caution is recommended when administering this medication to lactating individuals.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the drug insert regarding dosage adjustments, special monitoring, or safety considerations. Therefore, healthcare professionals should exercise caution when prescribing this medication to patients with reduced kidney function, as the absence of detailed guidance necessitates careful clinical judgment. Regular monitoring of renal function may be advisable in these patients to ensure safety and efficacy.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to this medication. Consequently, there are no dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the prescribing information.

Overdosage

In the event of an overdosage, immediate medical assistance is crucial. If the substance is swallowed, healthcare professionals should advise patients or caregivers to seek medical help without delay. It is recommended to contact a Poison Control Center at 1-800-222-1222 for expert guidance on managing the situation.

Prompt intervention is essential to mitigate potential adverse effects associated with overdosage. Healthcare providers should be prepared to assess the patient's condition and implement appropriate management strategies based on the severity of symptoms and the specific substance involved.

Nonclinical Toxicology

There is currently no available information regarding teratogenic or non-teratogenic effects associated with the compound. Additionally, no data has been provided concerning nonclinical toxicology, animal pharmacology, or toxicology studies. As such, a comprehensive assessment of these aspects cannot be made at this time.

Postmarketing Experience

Postmarketing experience has identified the following adverse reactions reported voluntarily or through surveillance programs: rash, itching, and excessive skin irritation. These events have been documented in the context of routine pharmacovigilance activities.

Patient Counseling

Healthcare providers should advise patients to seek immediate medical assistance or contact a Poison Control Center at 1-800-222-1222 if the product is swallowed. It is important to instruct patients not to use the product on wounds or damaged skin, and to avoid using it in conjunction with a heating pad.

Patients should be informed that they must not use the product if they are allergic to any of its ingredients and should only use it as directed. They should be cautioned to stop use and consult a doctor if they experience rash, itching, or excessive skin irritation, or if their condition worsens. Additionally, patients should be advised to seek medical advice if symptoms persist for more than 7 days or if they resolve and then recur within a few days.

While using the product, patients should be instructed to avoid contact with the eyes, mucous membranes, or rashes, and to refrain from tightly bandaging the area. They should also be informed not to use the product simultaneously with other topical analgesics.

Healthcare providers should emphasize the importance of proper disposal of used patches, keeping them away from children and pets, as they still contain the drug product that can lead to serious adverse effects if ingested. Lastly, patients with a history of allergic reactions to aspirin or salicylates should be advised to consult a doctor before using this product.

Storage and Handling

The product is supplied in a clean, dry container designed to protect its contents from excessive moisture and direct sunlight. It is essential to store the product in a location that maintains these conditions to ensure its integrity and efficacy. The recommended storage environment should be free from humidity and should not expose the product to direct light.

Additional Clinical Information

The medication is administered percutaneously via a topical transdermal route, with a recommended application frequency of 3 to 4 times daily. It should not be used for more than 8 hours at a time. Clinicians should advise patients who are pregnant or breastfeeding to consult a healthcare professional prior to use. Additionally, it is important for patients to dispose of used patches safely, keeping them away from children and pets, as they may still contain active drug that could lead to serious adverse effects if ingested.

No further information is available regarding laboratory tests, abuse potential, or postmarketing experiences.

Drug Information (PDF)

This file contains official product information for Equate Pain Relief Patch Camphor/Menthol/Salicylate, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)